http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-31254-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_071951dd7dfb2d38df0b292f2d09957f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd07a5abded04b652dc49b494c349978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d3758a61f46c6d7d3dd75076b6df434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8eb8debc9b9e8f2b305b20b74a44431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_696706c7057a678b373ddb0e826386c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a97485d74758d7e73d7c695d2b6db08
publicationDate 2008-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-31254-U
titleOfInvention METHOD FOR ASSESSING THE EFFECTIVENESS OF ACTION
abstract A method for assessing the effectiveness of the use of acton by physiological studies of its actoprotective properties. In this case, the fatty acid composition of the lipid tissues of rat skeletal muscle, liver and myocardium is determined using gas-liquid chromatography, metabolic changes in the content of palmitic, oleic, linoleic and arachidonic fatty acids are detected before and after the use of acton, compared with the control, and when the parameters are normalized, the effectiveness of the drug is evaluated.
priorityDate 2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456126543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985

Total number of triples: 18.